167 - Phase 3, Randomized, Controlled Trial Evaluating Safety, Efficacy, and Pharmacokinetics (PK) of Clesrovimab in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease

Thursday, October 17, 2024

2:21 PM – 2:33 PM US PT

Location: 403 A

Co-Author(s)

HZ

Heather J. Zar, PhD

Red Cross Children's Hospital and SA-MRC Unit on Child & Adolescent Health, University of Cape Town, South Africa
Cape Town, Western Cape, South Africa
LB

Louis J. Bont, MD

University Medical Centre Utrecht
Zeist, Utrecht, Netherlands
PM

Paolo Manzoni, MD, PhD

University of Torino
Torino, Piemonte, Italy
Flor M. Munoz, MD, MSc

Associate Professor of Pediatrics
Baylor College of Medicine
Houston, TX, United States

Presenting Author(s)

OR

Octavio Ramilo, MD

Chair
St. Jude Children's Research Hospital
Memphis, TN, United States

Slides

Co-Author(s)

PC

Po-Yen Chen, MD

Taichung Veterans General Hospital
Taichung, Taitung, Taiwan
JN

Jose M. Novoa Pizarro, MD

Hospital Padre Alberto Hurtado
Santiago, Region Metropolitana, Chile
GO

Gustavo A. Ordonez, MD

Univeridad Del Valle
Cali, Valle del Cauca, Colombia
MT

Maria Tsolia, MD, PhD

National and Kapodistrian University of Athens
Athens, Attiki, Greece
BT

Bruce Tapiero, MD

CHU Sainte-Justine
Montreal, Quebec, Canada
MA

Mirta Acuña, MD

infectious disease MD
Roberto del rio children hospital
Santiago, Region Metropolitana, Chile
JC

Javier M. Castellanos, MD

Morales Vargas Centro de Investigacion
Leon, Guanajuato, Mexico
MM

Michael Meyer, MD

Middlemore Hospital
Auckland, Auckland, New Zealand
IM

Ichiro Morioka, MD, PhD

Nihon University Itabashi Hospital
Tokyo, Tokyo, Japan
ZC

Ziqiang Chen, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
RR

Radha A. Railkar, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
XZ

Xiaowei Zang, PhD

Merck & Co., Inc.
RAhway, New Jersey, United States
AK

Andrea L. Krick, PhD

Merck & Co., Inc.
Rahway, New Jersey, United States
AL

Andrew W. Lee, MD

Merck & Co., Inc., present affiliation Uniquity Bio, Malvern, PA, USA
Rahway, New Jersey, United States
LC

Luis A. Castagnini, MD, MPH

Merck & Co., Inc.
Rahway, New Jersey, United States
Anushua Sinha, MD, MPH

Director
Merck and Co Inc.
Rahway, NJ, United States

Disclosure(s):

Heather J. Zar, PhD: MSD, Pfizer, AstraZeneca, Moderna (DSMB): Advisor/Consultant, Grant/Research Support, Honoraria, MSD Principal Investigator for the study and on MSD Advisory Board

Louis J. Bont, MD: Pfizer, AstraZeneca, Sanofi, Janssen, MeMed Diagnostics, Gates Foundation, GSK, Novavax, Julius Clinical, Ablynx, Bavaria Nordic, Moderna, and MSD: Advisor/Consultant, Board Member, Grant/Research Support, Honoraria, Regular interaction with pharmaceutical & other industrial partners.Founding chairman-ReSViNET Foundation.Received minor institutional funding to UMCU

Paolo Manzoni, MD, PhD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Advisor/Consultant, SAC member for MSD

Flor M. Munoz, MD, MSc: Pfizer, DMC-Moderna, Meissa, Sanofi, AstraZeneca, Novavax, Gilead, MSD: Advisor/Consultant, Grant/Research Support, SAC member for MSD

Octavio Ramilo, MD: Pfizer, Sanofi, Gates Foundation, NIH, and Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Advisor/Consultant, Grant/Research Support, Honoraria, SAC member for MSD

Po-Yen Chen, MD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Princial Investigator for MSD

Jose M. Novoa Pizarro, MD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Principal Investigator for the study for MSD

Gustavo A. Ordonez, MD: Megalabs, Tecnoquimicas SA and MSD: Grant/Research Support, Honoraria, Principal Investigator for the study for MSD

Maria Tsolia, MD, PhD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Princial Investigator for MSD

Bruce Tapiero, MD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Princial Investigator for MSD

Mirta Acuña, MD: Pfizer, Janssen, Sanofi, and MSD: Advisor/Consultant, Grant/Research Support, Principal Investigator for Janssen, Sanofi and MSD

Javier M. Castellanos, MD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Princial Investigator for MSD

Michael Meyer, MD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Princial Investigator for MSD

Ichiro Morioka, MD, PhD: AstraZeneca K.K.: Honoraria; Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Honoraria, Princial Investigator for MSD; Mitsubishi Tanabe Pharma Corporation: Honoraria; Pfizer Japan Inc.: Honoraria; Sanofi K.K.: Honoraria; Shino-Test Corporation: Grant/Research Support

Ziqiang Chen, PhD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Employee, Stocks/Bonds (Public Company)

Radha A. Railkar, PhD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, US (MSD): Employee, Stocks/Bonds (Public Company)

Xiaowei Zang, PhD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Employee, Stocks/Bonds (Public Company)

Andrea L. Krick, PhD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Employee, Stocks/Bonds (Public Company)

Andrew W. Lee, MD: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Employee at the time of study, Stocks/Bonds (Public Company)

Luis A. Castagnini, MD, MPH: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Employee, Stocks/Bonds (Public Company)

Anushua Sinha, MD, MPH: Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA (MSD): Employee, Stocks/Bonds (Public Company)